Half-year report · HY
3840.TEDINET S100X3IZ
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥323m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥84m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥324m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥229m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥78m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥321m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥79m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥320m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥647m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥777m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥98m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥155m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥98m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥190m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥182m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥539m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥248m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥199m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥525m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥324m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥573m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.25 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 79.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥74m |
| AI Technologyreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥22m |
| AI Technologyreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥67m |
| Beauty And Wellness Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥429m |
| Beauty And Wellness Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥39m |
| Cosmetics Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥539m |
| Cosmetics Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥84m |
| Investment Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥20m |
| Investment Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥18m |
| Market Expansion Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1m |
| Market Expansion Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥50,000 |
| Market Expansion Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥21m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥258m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥254m |
| Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥26m |
| Sustainable Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥919,000 |
| Sustainable Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥30m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥4m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | −¥249m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥58m |
| Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥500m |
| Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥439m |
| Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥181m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| Sustainable Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3m |
| Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥29m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥26m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 527
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)フロンティア監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)藤井 幸雄 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)酒井 俊輔 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 1123910000 | JPY |
| Net sales (5-year summary) | InterimDuration | 1265950000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 2253739000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | -77978000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | -323989000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -228919000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | -81548000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | -320059000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -276771000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | -81548000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | -320059000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -276771000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 1362464000 | JPY |
| Net assets (5-year summary) | InterimInstant | 2505861000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2474877000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 2056416000 | JPY |
| Total assets (5-year summary) | InterimInstant | 3153201000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 3252288000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | -1.38 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | -4.25 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -4.36 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.659 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.790 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.755 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | -248168000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | -181906000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -538514000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -431735000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -199230000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -525282000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | 573109000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 324007000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 914000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 189792000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 97535000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 154663000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 76785036 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 77235036 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 76785036 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 77235036 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 30066200 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.392 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |